Impact of active screening for methicillin-resistant Staphylococcus aureus (MRSA) and decolonization on MRSA infections, mortality and medical cost: a quasi-experimental study in surgical intensive care unit.

Yuarn-Jang Lee, Jen-Zon Chen, Hsiu-Chen Lin, Hsin-Yi Liu, Shyr-Yi Lin, Hsien-Ho Lin, Chi-Tai Fang, Po-Ren Hsueh
Author Information
  1. Yuarn-Jang Lee: Division of Infectious Diseases, Department of Internal Medicine, Taipei Medical University Hospital, 252 Wusing Street, Taipei, 11031, Taiwan. yuarn438@yahoo.com.tw.
  2. Jen-Zon Chen: Department of Infection Control, Taipei Medical University Hospital, 252 Wusing Street, Taipei, 11031, Taiwan. icn@h.tmu.edu.tw.
  3. Hsiu-Chen Lin: Department of Pediatrics, School of Medicine, College of Medicine, Taipei Medical University, 250 Wusing Street, Taipei, 11031, Taiwan. jane217@mail.tmuh.org.tw.
  4. Hsin-Yi Liu: Division of Infectious Diseases, Department of Internal Medicine, Taipei Medical University Hospital, 252 Wusing Street, Taipei, 11031, Taiwan. b8601032@tmu.edu.tw.
  5. Shyr-Yi Lin: Department of General Medicine, School of Medicine, College of Medicine, Taipei Medical University, 250 Wusing Street, Taipei, 11031, Taiwan. sylin@tmu.edu.tw.
  6. Hsien-Ho Lin: Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, 17 Xu-Zhou Road, Taipei, 10002, Taiwan. hsienho@ntu.edu.tw.
  7. Chi-Tai Fang: Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, 17 Xu-Zhou Road, Taipei, 10002, Taiwan. fangct@ntu.edu.tw.
  8. Po-Ren Hsueh: Department of Internal Medicine, National Taiwan University Hospital, 7 Chun-Shan South Road, Taipei, 10002, Taiwan. hsporen@ntu.edu.tw.

Abstract

INTRODUCTION: Methicillin-resistant Staphylococcus aureus (MRSA) is a leading pathogen of healthcare-associated infections in intensive care units (ICUs). Prior studies have shown that decolonization of MRSA carriers is an effective method to reduce MRSA infections in ICU patients. However, there is currently a lack of data on its effect on mortality and medical cost.
METHODS: Using a quasi-experimental, interrupted time-series design with re-introduction of intervention, we evaluated the impact of active screening and decolonization on MRSA infections, mortality and medical costs in the surgical ICU of a university hospital in Taiwan. Regression models were used to adjust for effects of confounding variables.
RESULTS: MRSA infection rate decreased from 3.58 (baseline) to 0.42‰ (intervention period) (P <0.05), re-surged to 2.21‰ (interruption period) and decreased to 0.18‰ (re-introduction of intervention period) (P <0.05). Patients admitted to the surgical ICU during the intervention periods had a lower in-hospital mortality (13.5% (155 out of 1,147) versus 16.6% (203 out of 1,226), P = 0.038). After adjusting for effects of confounding variables, the active screening and decolonization program was independently associated with a decrease in in-hospital MRSA infections (adjusted odds ratio: 0.3; 95% CI: 0.1 to 0.8) and 90-day mortality (adjusted hazard ratio: 0.8; 95% CI: 0.7 to 0.99). Cost analysis showed that $22 medical costs can be saved for every $1 spent on the intervention.
CONCLUSIONS: Active screening for MRSA and decolonization in ICU settings is associated with a decrease in MRSA infections, mortality and medical cost.

References

  1. N Engl J Med. 2013 Feb 7;368(6):533-42 [PMID: 23388005]
  2. N Engl J Med. 2010 Jan 7;362(1):9-17 [PMID: 20054045]
  3. PLoS One. 2013;8(8):e71055 [PMID: 23940689]
  4. Infect Control Hosp Epidemiol. 2010 May;31(5):558-60 [PMID: 20334509]
  5. Infect Control Hosp Epidemiol. 2010 Aug;31(8):779-83 [PMID: 20594110]
  6. Int J Antimicrob Agents. 2010 Oct;36(4):307-12 [PMID: 20685086]
  7. Clin Microbiol Infect. 2011 Feb;17(2):146-54 [PMID: 20219085]
  8. N Engl J Med. 2011 Apr 14;364(15):1407-18 [PMID: 21488763]
  9. N Engl J Med. 2011 Apr 14;364(15):1419-30 [PMID: 21488764]
  10. PLoS One. 2011;6(8):e23001 [PMID: 21857979]
  11. Clin Infect Dis. 2012 Jun;54(11):1618-20 [PMID: 22491330]
  12. BMC Infect Dis. 2012;12:302 [PMID: 23151152]
  13. Crit Care Med. 2013 Jul;41(7):1711-8 [PMID: 23660729]
  14. N Engl J Med. 2013 Jun 13;368(24):2314-5 [PMID: 23718155]
  15. PLoS One. 2014;9(5):e96310 [PMID: 24836438]
  16. N Engl J Med. 2001 Jan 4;344(1):11-6 [PMID: 11136954]
  17. Emerg Infect Dis. 2001 Mar-Apr;7(2):327-32 [PMID: 11294734]
  18. Taiwan Yi Xue Hui Za Zhi. 1988 Feb;87(2):157-63 [PMID: 3397714]
  19. Am J Infect Control. 1988 Jun;16(3):128-40 [PMID: 2841893]
  20. Lancet. 1963 Apr 27;1(7287):904-7 [PMID: 13957735]
  21. J Hosp Infect. 2005 Mar;59(3):205-14 [PMID: 15694977]
  22. Clin Microbiol Infect. 2005 Jun;11(6):466-71 [PMID: 15882196]
  23. Lancet Infect Dis. 2005 Dec;5(12):751-62 [PMID: 16310147]
  24. J Am Med Inform Assoc. 2006 Jan-Feb;13(1):16-23 [PMID: 16221933]
  25. J Antimicrob Chemother. 2006 Mar;57(3):511-9 [PMID: 16443700]
  26. Infect Control Hosp Epidemiol. 2006 Feb;27(2):185-7 [PMID: 16465636]
  27. Clin Infect Dis. 2006 Oct 15;43(8):971-8 [PMID: 16983607]
  28. Infect Control Hosp Epidemiol. 2006 Nov;27(11):1264-6 [PMID: 17080390]
  29. Infect Control Hosp Epidemiol. 2007 Oct;28(10):1155-61 [PMID: 17828692]
  30. Clin Infect Dis. 2008 Jun 1;46(11):1717-25 [PMID: 18494098]
  31. Am J Infect Control. 2008 Jun;36(5):309-32 [PMID: 18538699]
  32. Clin Infect Dis. 2009 Sep 15;49(6):935-41 [PMID: 19673644]
  33. N Engl J Med. 2013 Jun 13;368(24):2255-65 [PMID: 23718152]

MeSH Term

Aged
Anti-Bacterial Agents
Anti-Infective Agents, Local
Carrier State
Chlorhexidine
Cross Infection
Disinfection
Female
Hospital Mortality
Humans
Infection Control
Intensive Care Units
Male
Methicillin-Resistant Staphylococcus aureus
Middle Aged
Mupirocin
Nasal Cavity
Staphylococcal Infections
Taiwan

Chemicals

Anti-Bacterial Agents
Anti-Infective Agents, Local
Mupirocin
chlorhexidine gluconate
Chlorhexidine

Word Cloud

Created with Highcharts 10.0.0MRSA0infectionsmortalitydecolonizationmedicalinterventionICUscreeningactivesurgicalperiod1Staphylococcusaureusintensivecarecostquasi-experimentalre-introductioncostseffectsconfoundingvariablesdecreased3P<005in-hospitalassociateddecreaseadjustedratio:95%CI:8INTRODUCTION:Methicillin-resistantleadingpathogenhealthcare-associatedunitsICUsPriorstudiesshowncarrierseffectivemethodreducepatientsHowevercurrentlylackdataeffectMETHODS:Usinginterruptedtime-seriesdesignevaluatedimpactuniversityhospitalTaiwanRegressionmodelsusedadjustRESULTS:infectionrate58baseline42‰re-surged221‰interruption18‰Patientsadmittedperiodslower135%155147versus166%203226P = 0038adjustingprogramindependentlyodds90-dayhazard799Costanalysisshowed$22cansavedevery$1spentCONCLUSIONS:ActivesettingsImpactmethicillin-resistantcost:studyunit

Similar Articles

Cited By